Gail K Naughton is Director of TherapeuticsMD, Inc.. Currently has a direct ownership of 0 shares of TXMD, which is worth approximately $0. The most recent transaction as insider was on Dec 07, 2022, when has been sold 3,922 shares (Common Stock) at a price of $5.26 per share, resulting in proceeds of $20,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Gail K Naughton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2022
SELL
Open market or private sale
$20,629 $5.26 p/Share
3,922 Reduced 100.0%
0 Common Stock
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
1,984 Added 33.59%
3,922 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
-
96,864 Added 50.0%
96,864 Common Stock

Also insider at

HSTO
Histogen Inc. Healthcare
CVM
CEL SCI CORP Healthcare
GKN

Gail K Naughton

Director
Boca Raton, FL

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Track Activities on TXMD